Sanofi-Aventis Picks Two To Head U.S.: Rothwell, Soriot On Management Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi's Tim Rothwell will continue to serve as U.S. CEO, while Aventis' Soriot will head U.S. commercial operations. French market regulator extends closing date of merger to July 30, citing extra time needed for FTC review.